- Published on 16 February 2015
Brazilian Ministry of Health Decree 2.776 of December 18, 2014, has established new standards for the surgical treatment of deafness through the Sistema Único de Saúde, the country’s publicly funded health system.
The new regulation supersedes Decree 1.278 in force since 1999, which set the rules for cochlear implants in the Brazilian public sector for 15 years. Decree 2.776 includes a range of new procedures (now 24 instead of 4), including simultaneous and sequential bilateral cochlear implant in children aged under 7 years, and in teenagers and adults with post-lingual deafness.
For the former group, bilateral CI depends on several conditions, among which not benefiting from bimodal fitting (CI+HA), scoring 50% or less on open-set sentences testing, and adequate rehabilitation conditions in the city of residency. Furthermore, teenagers and adults who meet the criteria have to undergo sequential CI, since the first implant must have been proven effective before implanting the second. Another improvement is a 6-year free-of-charge warranty for all devices’ external parts, and sound processor replacement after six years. The decree also includes bone-anchored hearing aids in the government’s hearing health policy.
Besides new procedures, the new decree also obliges CI hospitals to request a new qualification with requirements exceeding those of the former regulation. For instance, the Brazilian Ministry of Health aims to increase knowledge in hospitals with little CI experience. Hospitals with less than 10 years’ qualification in the CI government program or less than 240 CIs need to qualify their otolaryngology surgeons with a 60-hour course on CIs and bone-anchored HAs, an 80-hour practical internship, and the follow-up of 20 surgeries (10 in adults and 10 in children).
Source: Audiology Infos Brazil
People in hearing need to connect to each other. Partnership deals can open up networks to thousands of independent practices, for profit or for quality care. It's a busy time for such deals within the wheels of the audiology world.
A drug shown in trials to relieve tinnitus and sensorineural hearing loss symptoms in Meniere's disease (MD) sufferers is being fast-tracked the the US Food and Drug Administration's (FDA) stringent new drug application process.
Researchers from Xiangya Hospital in China's Hunan Province have discovered a gene associated with hearing loss, a breakthrough that should help in diagnosis and treatment strategies.
Dortmund in Germany is the location for a new ultra-modern training centre opened by the hearing device manufacturer Sonova Holding AG.
Prolonged use of sound amplification apps such as Google's Sound Amplifier may cause hearing problems instead of easing them, warns the National Association of Audiologists of Spain (ANA).
There will be a massive roar in Japanese stadiums hosting the Rugby World Cup, which starts on Friday September 20, but it will barely compete with the street noise in the country with the world's worst acoustic pollution problem.
In a move that Apple claims will allow customers to contribute to medical discoveries, the phone and computer giant is to conduct three large-scale health studies, one of them into the impact of everyday sound exposure on hearing.
Oticon completes its hearing aid portfolio with the launch of the Oticon Xceed and Oticon Xceed Play power hearing aids for profound hearing loss. Hearing care professionals now have access to the most updated hearing aid portfolio on the market with a complete range of hearing aids, all featuring the Velox S platform.[ ... ]
Phonak, the world’s leading hearing aid provider, has launched Marvel 2.0, "the next generation of Marvel technology developed to give hearing aid wearers even more hearing performance, more connectivity and more choice".[ ... ]